Neogen Corporation (NEOG)
Neogen Corporation: Promising Recurring Demand With Food Safety
I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITDA margins of approximately 30% and free-cash-flow conversion of about 80% by fiscal 2031.
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation (NEOG) Q1 2027 Earnings Call Transcript
Neogen Corporation (NEOG) Q1 2027 Earnings Call Transcript
What Neogen (NEOG) Said on Its Q1 Earnings Call
Neogen NASDAQ: NEOG reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition.
Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates
Neogen (NEOG) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.04 per share a year ago.
Neogen Shareholders Approve Board Elections, Pay and Equity Plan Amendments
Neogen NASDAQ: NEOG shareholders approved all five proposals presented at the company's 2026 annual meeting, including the election of three directors, advisory approval of executive compensation, and amendments to the company's equity incentive and employee stock purchase plans.
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
NEOG's 83% YTD rally reflects Food Safety momentum, Petrifilm expansion, solutions-based selling and a growing product pipeline.
Is This the Right Time to Add Neogen Stock to Your Portfolio?
NEOG advances product innovation and recovers Animal Safety operations, but high debt and intense competition remain key risks.
Neogen Surges 102.8% in a Year: What's Driving the Rally?
NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks.
Neogen (NEOG) is a Great Momentum Stock: Should You Buy?
Does Neogen (NEOG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock
Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
